The Helmholtz Center Infection Research Institute in Germany published a communiqué on the 25th that the institute discovered a method that can double the output of insulin precursors and decided to disclose all technical details without registering patents in order to make more, especially development People with diabetes in China can get medication.

At present, the insulin preparations used in clinical treatment are made from converted insulin precursors, which are mainly produced in Escherichia coli or Saccharomyces cerevisiae. On this basis, the Institute discovered a new method that can double the output of insulin precursors, thereby reducing the cost of insulin production. The insulin produced by this method has been proven to be safe for human use.

The communique said that diabetes is no longer the "rich disease" previously considered. The number of patients in developing countries is growing rapidly, but patients in many poor countries suffer from torture or even lose their lives because they cannot afford medicines. The important reason is that many new drugs and methods have applied for patent protection, resulting in high treatment costs. The goal of this research project at the Helmholtz Center for Infection Research is to reduce insulin production costs and benefit more diabetics. This result was published in the network science magazine "Microbial Cell Factory".

Stainless Steel Collecting Cart

Stainless Steel Gathering Cart,Metallic Collection Trolley,Stainless Storage Cart

Jiangmen Xinweijie Stainless Steel Products Co., Ltd. , https://www.xxdkitchenware.com